search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
580


| INTRODUCTION


Equine anoplocephalid cestodes occur worldwide in horses (Gasser et al., 2005 ). There are currently three species of tapeworm known to infect horses: Anoplocephala perfoliata , A. magna and Anoplocephaloides mamillana . The most common of these three is A. perfoliata , with the other two being much more sporadic in appear- ance (Borgsteede & van Beek, 1998 ; Meana et al., 2005 ; Rehbein et al., 2012 ). In the US, A. perfoliata has been reported with infection rates of 52–100% (Chapman et al., 2003 ; Lyons et al., 2000 , 2007 ). In terms of predilection site within the horse, A. mamillana and A. magna follow typical tapeworm behaviour and are located within the small intestine. A. perfoliata , however, instead resides around the ileocaecal junction within the caecum. Currently, only A. perfoliata has been associated with clinical disease in horses. These parasites cause inflammatory reactions around their attachment site, which have been characterised by mucosal thickening, necrotic ulcers and hyperaemia (Kjaer et al., 2007 ; Nilsson et al., 1995 ; Pearson et al., 1993 ; Williamson et al., 1997 ). Common disease manifestations of tapeworm infection include intussusceptions, bowel obstructions, cecal perforations and peritonitis (Barclay et al., 1982 ; Beroza et al., 1983 ; Owen et al., 1989 ). Clinically, A. perfoliata infection has been associated with colic manifestations in several studies (Back et al., 2013 ; Proudman et al., 1998 ; Proudman & Edwards, 1993 ). There are currently two registered and marketed anthelmintic


compounds with documented activity against equine tapeworms, which are pyrantel pamoate/embonate and praziquantel. Pyrantel pamoate/embonate was originally introduced in the 1970s. This an- thelmintic originally reduced A. perfoliata worm burdens by around 80% when given the standard dose labelled for nematode control (6.6 mg base/kg; Lyons et al., 1989 ). However, when the dosage was doubled to 13.2 mg base/kg, the anticestodal efficacy increased to 95–98% (Marchiondo et al., 2006 ; Reinemeyer et al., 2006 ). Praziquantel was introduced later in the 1990s and is usually com- bined with ivermectin or moxidectin in anthelmintic formulations. Praziquantel is administered as a paste at a dosage of 1.0–2.5 mg/ kg and has efficacy against the three equine tapeworm species, with efficacy percentages ranging from 90.8% to 100% against A. perfoliata , and 100% for both A. magna and A. mamillana (Rehbein et al., 2007 ; Slocombe et al., 2007 ). Recently, we have reported evidence of anticestodal treatment


failure in a Central Kentucky Thoroughbred farm with faecal egg count data demonstrating reduced efficacy of pyrantel pamoate and praziquantel (Nielsen, 2023 ). The current study took place on a dif- ferent Thoroughbred farm in an adjacent county. In the previously published study, praziquantel only reduced eggs in 3/17 infected horses, while pyrantel pamoate reduced none (Nielsen, 2023 ). Anecdotal evidence has also previously suggested the possibility of pyrantel- resistant tapeworms in Ontario, Canada, but treatment efficacy data was lacking at the time (Peregrine et al., 2008 ). It is worth noting that in other species of platyhelminthes, evidence of praziquantel resistance has been reported in the canine ces- tode Dipylidium caninum (Jesudoss Chelladurai et al., 2018 ) and the


FINNERTY ET AL.


human trematodes Schistosoma spp. (Vale et al., 2017 ). Due to the evidence of drug resistance in these related parasites, it is entirely possible that drug resistance could develop in other platyhelminth species as well. Currently, there are three methods to diagnose equine tape-


worm infection antemortem: faecal egg counting, enzyme- linked immunosorbent assay (ELISA) saliva testing and ELISA serum testing (Lightbody et al., 2016 ; Proudman & Trees, 1996 ). The ELISA serum and saliva tests are not useful for treatment efficacy evaluation because the anticestodal antibodies do not disappear sufficiently quickly, which can create false positives when tapeworm infections have been eliminated (Abbott et al., 2008 ; Lightbody et al., 2016 ). For faecal egg counting, multiple methods have been described. The McMaster technique has been demonstrated to perform with a diagnostic sensitivity of less than 10% for detecting A. perfoliata (Hreinsdóttir et al., 2019 ; Meana et al., 1998 ; Tomczuk et al., 2014 ). Though modified egg counting techniques exist, they lack sensitiv- ity for detecting burdens under 20 worms (Gawor, 1995 ; Gundlach et al., 2003 ; Proudman & Edwards, 1992 ). Despite these limitations, faecal egg counting techniques have been utilised in field efficacy studies for both pyrantel pamoate and praziquantel providing useful information of field efficacy despite the often sporadic and low pos- itive counts (Marchiondo et al., 2006 ; Proudman & Edwards, 1992 ; Slocombe et al., 2007 ). For pyrantel pamoate, horses were adminis- tered the standard 13.2 base mg/kg with a mean tapeworm faecal egg count reduction of around 95% (Marchiondo et al., 2006 ). For praziquantel, a study demonstrated 90.9–100% egg count reduc- tion, and horses remained negative for tapeworm counts at five weeks post- treatment (Slocombe et al., 2007 ). Similarly, in Kentucky, yearlings were treated with ivermectin- praziquantel and had over 90% reduction of anoplocephalid egg counts, with evidence of reemergence not beginning until 4 weeks post- treatment


(Lyons


et al., 2017 ). This current study aimed to describe a case of apparent treat-


ment failure of pyrantel pamoate and praziquantel against equine tapeworms in a group of Thoroughbred yearlings followed over a 6- month period.


ANIMAL USAGE


Twenty- four yearlings from one Thoroughbred breeding farm in Central Kentucky were enrolled in the study after they were found to have evidence of tapeworm eggs 14 days post- treatment with praziquantel (1 mg/kg) and ivermectin (0.2 mg/kg; Zimectrin Gold, Boehringer Ingelheim) in March 2022 following routine measures in place on the farm. There were 16 female yearlings and 8 male yearlings born between 5 February and 9 May 2021. Yearlings were separated by sex, with no more than 8 yearlings per pasture, with pasture rotations occurring every 2–3 months. Historically, this farm has regularly utilised praziquantel and pyrantel pamoate as part of their protocol for tapeworm management in their yearling herds. The horses were followed from March to August 2022 until they


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92